ClinicalTrials.govpublic full text
CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy
age-related muscle decline, sarcopenia, muscle atrophy, skeletal muscle, muscle weakness, muscle strength, aging, frailty, follistatin, myostatin, viral vectors, adeno-associated viruses
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 807185
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.